L3VLUP
ProSign in

RXRX in the 13F filings

Recursion Pharmaceuticals Inc · CUSIP 75629V104

Sector · Pharmaceuticals and biotechnologyTheme · Biological productsTheme · Healthcare: biopharma and medtech· L3VLUP-defined
Quarter
Q3 2026 · early filersQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
30 Jun 2026
the date the book describes
Filed
27 Oct 2026
latest of these filings; the earliest 6 Aug 2026
Managers listing it
25
at least, of 95 tracked, among listed positions
Comparable managers
91
filed both Q1 2026 and Q2 2026; 2 listed it in both
Shares listed
83,789,902
combined, among listed positions
Reported value
$307m
combined, at the quarter end

AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.

Among the 91 comparable managers: 13 buyers (opened or added shares) and 14 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -3,341,306.

Managers listing RXRX in Q2 2026

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q1 2026, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

25 of 25 holders

ActionFiling
ARK Investment Management LLC41,337,632$152m0.98%Added+1,124,86314 Aug 2026 (the filing on sec.gov)
Baillie Gifford & Co23,487,907$86m0.08%Trimmed-187,5006 Aug 2026 (the filing on sec.gov)
Marshall Wace LLP4,714,577$17munder 0.1%Added+1,837,64913 Aug 2026 (the filing on sec.gov)
Two Sigma Investments LP3,353,658$12munder 0.1%Trimmed-712,65714 Aug 2026 (the filing on sec.gov)
Susquehanna International Group LLP3,292,128$12munder 0.1%Trimmed-933,14914 Aug 2026 (the filing on sec.gov)
Millennium Management LLC1,834,762$6.7munder 0.1%Trimmed-777,51514 Aug 2026 (the filing on sec.gov)
Invesco Ltd795,698$2.9munder 0.1%Added+104,54514 Aug 2026 (the filing on sec.gov)
Man Group PLC765,786$2.8munder 0.1%Trimmed-433,77714 Aug 2026 (the filing on sec.gov)
T. Rowe Price Associates Inc720,097$2.6munder 0.1%Added+159,35114 Aug 2026 (the filing on sec.gov)
Verition Fund Management LLC446,947$1.6munder 0.1%Added+34,20014 Aug 2026 (the filing on sec.gov)
AQR Capital Management LLC422,087$1.5munder 0.1%Added+177,69614 Aug 2026 (the filing on sec.gov)
Schonfeld Strategic Advisors LLC416,869$1.5munder 0.1%Added+332,31314 Aug 2026 (the filing on sec.gov)
AllianceBernstein LP472,284$1.4munder 0.1%Added+14,78014 Aug 2026 (the filing on sec.gov)
Balyasny Asset Management LLC353,661$1.3munder 0.1%Added+186,61314 Aug 2026 (the filing on sec.gov)
ExodusPoint Capital Management LP248,783$913kunder 0.1%Trimmed-97,96714 Aug 2026 (the filing on sec.gov)
Janus Henderson Group Ltd220,309$810kunder 0.1%Held014 Aug 2026 (the filing on sec.gov)
Winton Group Ltd192,800$708kunder 0.1%Added+88,7007 Aug 2026 (the filing on sec.gov)
Wellington Management Group LLP180,598$663kunder 0.1%Added+29,17914 Aug 2026 (the filing on sec.gov)
Hudson Bay Capital Management LP160,000$587kunder 0.1%Trimmed-375,73014 Aug 2026 (the filing on sec.gov)
Citadel Advisors LLC128,478$472kunder 0.1%Trimmed-496,1812 Sep 2026 (the filing on sec.gov)
Squarepoint Ops LLC98,426$361kunder 0.1%Added+45,43814 Aug 2026 (the filing on sec.gov)
Fidelity (FMR LLC)46,356$170kunder 0.1%Trimmed-690,29813 Aug 2026 (the filing on sec.gov)
D. E. Shaw & Co.37,914$139kunder 0.1%Trimmed-8,09414 Aug 2026 (the filing on sec.gov)
Bridgewater Associates LP37,667$138kunder 0.1%Newnew14 Aug 2026 (the filing on sec.gov)
Neuberger Berman Group LLC24,478$90kunder 0.1%Trimmed-2,21627 Oct 2026 (the filing on sec.gov)

Largest increases and reductions, by shares

Q1 2026 to Q2 2026, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (1)

Exited (3)

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
3 in Q3 2024 to 2 in Q2 2026

Tracked managers listing it, at least.

012320222023202420252026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
RXRX by quarter
QuarterHoldersReported valueBuyersSellers
Q2 20212$763mn.a.n.a.
Q3 20212$567mn.a.n.a.
Q4 20212$417mn.a.n.a.
Q1 20222$178mn.a.n.a.
Q2 20222$193mn.a.n.a.
Q3 20222$266mn.a.n.a.
Q4 20222$215mn.a.n.a.
Q1 20232$192mn.a.n.a.
Q2 20232$223mn.a.n.a.
Q3 20232$240mn.a.n.a.
Q4 20232$442m11
Q1 20242$485m11
Q2 20243$415m30
Q3 20243$387m21
Q4 20242$387m02
Q1 20253$315m21
Q2 20252$289m02
Q3 20252$281m11
Q4 20252$250m188
Q1 20262$196m1712
Q2 20262$238m1314

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

RXRX and GILD →RXRX and AMGN →RXRX and ARGX →Choose a stock to compare with RXRX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own RXRX, latest filings →Back to the 13F Explorer →